23andMe, Inc. United States of America (USA)
Research
Date range: 1 December 2020 - 30 November 2021
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for 23andMe, Inc. published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
18 | 8.26 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 18 | 8.26 |
Physical Sciences | 1 | 0.01 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
1.82 | 1.55 | 1.36 | 2.72 | 3.06 |
Collaboration
Date range: 1 December 2020 - 30 November 2021
International vs. domestic collaboration by Share
- 31.25% Domestic
- 68.75% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with 23andMe, Inc. by Share (85 total)
-
23andMe, Inc. and Harvard University
(3.31)
-
23andMe, Inc. and Broad Institute of MIT and Harvard
(2.92)
-
23andMe, Inc. and Massachusetts Institute of Technology (MIT)
(2.83)
-
23andMe, Inc. and Washington University in St. Louis (WUSTL)
(1.78)
-
23andMe, Inc. and Vanderbilt University (VU)
(1.75)
-
23andMe, Inc. and University of California, San Diego (UC San Diego)
(1.55)
-
23andMe, Inc. and University of Michigan (U-M)
(1.42)
-
23andMe, Inc. and The University of North Carolina at Chapel Hill (UNC)
(1.38)
-
23andMe, Inc. and Amgen Inc.
(1.16)
-
23andMe, Inc. and Kaiser Permanente
(1.02)
Top 10 international collaborators with 23andMe, Inc. by Share (309 total)
-
23andMe, Inc. and Karolinska Institute (KI)
(1.90)
-
23andMe, Inc. and GlaxoSmithKline plc. (GSK)
(1.80)
-
23andMe, Inc. and UK Research and Innovation (UKRI)
(1.46)
-
23andMe, Inc. and Institute for Molecular Medicine Finland (FIMM)
(1.45)
-
23andMe, Inc. and University of Toronto (U of T)
(1.41)
-
23andMe, Inc. and University of Cambridge
(1.41)
-
23andMe, Inc. and University of Helsinki
(1.40)
-
23andMe, Inc. and Finland Ministry of Social Affairs and Health
(1.39)
-
23andMe, Inc. and The Hospital District of Helsinki and Uusimaa (HUS)
(1.39)
-
23andMe, Inc. and European Molecular Biology Laboratory (EMBL)
(1.38)
Relationships
Affiliated joint institutions and consortia

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.